DHG Pharmaceutical JSC Statistics

Total Valuation

DHG Pharmaceutical JSC has a market cap or net worth of VND 13.99 trillion. The enterprise value is 12.09 trillion.

Market Cap	13.99T
Enterprise Value	12.09T

Important Dates

The next estimated earnings date is Friday, October 18, 2024.

Earnings Date	Oct 18, 2024
Ex-Dividend Date	Aug 8, 2024

Share Statistics

DHG Pharmaceutical JSC has 130.75 million shares outstanding. The number of shares has decreased by -0.81% in one year.

Shares Outstanding	130.75M
Shares Change (YoY)	-0.81%
Shares Change (QoQ)	+7.01%
Owned by Insiders (%)	8.18%
Owned by Institutions (%)	0.45%
Float	n/a

Valuation Ratios

The trailing PE ratio is 17.19 and the forward PE ratio is 13.92.

PE Ratio	17.19
Forward PE	13.92
PS Ratio	2.80
PB Ratio	3.29
P/FCF Ratio	31.09
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.43, with an EV/FCF ratio of 26.87.

EV / Earnings	14.85
EV / Sales	2.42
EV / EBITDA	12.43
EV / EBIT	13.80
EV / FCF	26.87

Financial Position

The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.19.

Current Ratio	2.57
Quick Ratio	1.76
Debt / Equity	0.19
Debt / EBITDA	0.83
Debt / FCF	1.80
Interest Coverage	32.53

Financial Efficiency

Return on equity (ROE) is 19.38% and return on invested capital (ROIC) is 10.83%.

Return on Equity (ROE)	19.38%
Return on Assets (ROA)	9.22%
Return on Capital (ROIC)	10.83%
Revenue Per Employee	1.79B
Profits Per Employee	291.28M
Employee Count	2,789
Asset Turnover	0.84
Inventory Turnover	1.96

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.52% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-9.52%
50-Day Moving Average	108,206.00
200-Day Moving Average	110,895.50
Relative Strength Index (RSI)	43.63
Average Volume (20 Days)	17,420

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DHG Pharmaceutical JSC had revenue of VND 5.00 trillion and earned 813.84 billion in profits. Earnings per share was 6,224.62.

Revenue	5.00T
Gross Profit	2.18T
Operating Income	876.20B
Pretax Income	942.28B
Net Income	813.84B
EBITDA	972.90B
EBIT	876.20B
Earnings Per Share (EPS)	6,224.62

Full Income Statement

Balance Sheet

The company has 2.71 trillion in cash and 810.91 billion in debt, giving a net cash position of 1.90 trillion or 14,537.51 per share.

Cash & Cash Equivalents	2.71T
Total Debt	810.91B
Net Cash	1.90T
Net Cash Per Share	14,537.51
Equity (Book Value)	4.25T
Book Value Per Share	32,532.77
Working Capital	2.88T

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 768.98 billion and capital expenditures -319.07 billion, giving a free cash flow of 449.91 billion.

Operating Cash Flow	768.98B
Capital Expenditures	-319.07B
Free Cash Flow	449.91B
FCF Per Share	3,441.08

Full Cash Flow Statement

Margins

Gross margin is 43.57%, with operating and profit margins of 17.53% and 16.83%.

Gross Margin	43.57%
Operating Margin	17.53%
Pretax Margin	18.85%
Profit Margin	16.83%
EBITDA Margin	19.46%
EBIT Margin	17.53%
FCF Margin	9.00%

Dividends & Yields

This stock pays an annual dividend of 7,500.00, which amounts to a dividend yield of 7.01%.

Dividend Per Share	7,500.00
Dividend Yield	7.01%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	62.18%
Buyback Yield	0.81%
Shareholder Yield	7.82%
Earnings Yield	5.82%
FCF Yield	3.22%

Dividend Details

Stock Splits

The last stock split was on May 26, 2017. It was a forward split with a ratio of 1.5.

Last Split Date	May 26, 2017
Split Type	Forward
Split Ratio	1.5

Scores

DHG Pharmaceutical JSC has an Altman Z-Score of 7.19.

Altman Z-Score	7.19
Piotroski F-Score	n/a